Clinical Trials in Denver

Showing 2281-2300 of 15,604 trials

Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal

NCT03028857

The goal is to determine if providing a nutritional supplement, phosphatidylcholine, to pregnant women improves early brain development with improved brain-related development during the first four years of life. Participating pregnant women will receive either phosphatidylcholine or a placebo from approximately 16 weeks gestation through birth. The primary outcome is the child's behavior at four years of age as reported by the primary caregiver. Secondary outcomes include motor development, socio-emotional development, language development, and cognitive development. Potential contributors beyond the supplement, including maternal stress and placental function will also be assessed.

Child DevelopmentPrenatal Stress

University of Colorado, Denver216 participantsStarted Jun 2017

Aurora, Colorado, United States • Denver, Colorado, United States

RECRUITINGPhase 2< 1 mile

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

NCT07321678

This randomized, double-blind, placebo-controlled Phase II study is designed to evaluate the efficacy, safety, and tolerability of ASC30 oral tablets formulation in participants with Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Ascletis Pharma (China) Co., Limited100 participantsStarted Jan 2026

Riverside, California, United States • San Jose, California, United States • Denver, Colorado, United States +5 more locations

Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

Find Trials by Condition in Denver

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

Molgramostim Nebulizer Solution Expanded Access Program Protocol

Integrated Health Care for PTSD

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Acupuncture for Chronic Low Back Pain in Older Adults

AB154 Combined With AB122 for Recurrent Glioblastoma